The association between BMI and kidney cancer risk: An updated dose-response meta-analysis in accordance with PRISMA guideline
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Objective: Obesity is considered as one of the risk factors of kidney cancer. However, the results are not consistent in reported original studies, as well as in published meta-analysis. This study aims to clarify the relationship between overweight/obesity and kidney cancer by an updated overall and dose-response meta-analysis. Methods: This meta-analysis was conducted in accordance with PRISMA guideline. Relevant studies were searched using PubMed, Embase, and Web of Science databases. The studies were limited to human cohort studies in English and Chinese language. Random-effect models and dose-response meta-analysis were used to synthesize the results. Subgroup analyses were also conducted based on the characteristics of participants. Results: Twenty-four cohort studies with 8,953,478 participants were included in our meta-analysis. Compared to the normal weight, the pooled RRs of kidney cancer was 1.35 (1.27–1.43) in overweight and 1.76 (1.61–1.91) in obese participants. An increased kidney cancer risk of 1.06 (1.05–1.06) for each 1 kg/m 2 increase in BMI was showed in dose-response meta-analysis. No significant heterogeneity was found across studies with I 2 = 39.4% for overweight, and I 2 = 43.3% for obesity. Conclusion: The overall and dose-response meta-analysis suggested that overweight/obesity increases the risk of kidney cancer both in men and women.
Overview
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · cited 1×
“Publication bias was evaluated by the funnel plots and Egger’s regression test,([27]) and the trim-fill analysis was also applied.”
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“We used a random-effect model to analyze and report the results.([22]) Taking into account the heterogeneity between studies, we performed a 2-stage random-effect dose-response meta-analysis to calculate the trend based on relevant logRR estimated across BMI levels.”
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“We used the I(2) statistic and Q-test to assess heterogeneity across studies,([26]) and the no, low, moderate and high heterogeneity corresponded to the cut-points of 0%, 25%, 50% and 75%, respectively.”
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
Ljungberg, B., Bensalah, K., Canfield, S., Dabestani, S., Hofmann, F., Hora, M., Kuczyk, M. A., Lam, T., Marconi, L., Merseburger, A. S., et al. (2015) · European Urology · doi:10.1016/j.eururo.2015.01.005 · Cited by 3,394
Dose‐response analyses using restricted cubic spline functions in public health research
Desquilbet, L., & Mariotti, F. (2010) · Statistics in Medicine · doi:10.1002/sim.3841 · Cited by 1,980 · cited 1×
“We calculated the nonlinear P-value by testing the null hypothesis that the second spline coefficient is equal to zero.([25]) We used the I(2) statistic and Q-test to assess heterogeneity across studies,([26]) and the no, low, moderate and high heterogeneity corresponded to the cut-points of 0%, 25%, 50% and 75%, resp…”
Reeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507 · cited 1×
“Of the 14 studies, eight([35,37,38,40,43,44,47,50]) reported outcomes in men and women separately, and six([28,30,34,36,41,48]) offered data of both sex combined.”
Epidemiology and risk factors for kidney cancer
Chow, W.-H., Dong, L. M., & Devesa, S. S. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.46 · Cited by 1,384
Orsini, N., Li, R., Wolk, A., Khudyakov, P., & Spiegelman, D. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr265 · Cited by 1,280 · cited 1×
“Taking into account the heterogeneity between studies, we performed a 2-stage random-effect dose-response meta-analysis to calculate the trend based on relevant logRR estimated across BMI levels.([23]) In the first stage, a generalized least squares regression was used to estimate the restricted cubic spline model dis…”
Generalized Least Squares for Trend Estimation of Summarized Dose–response Data
Orsini, N., Bellocco, R., & Greenland, S. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600103 · Cited by 1,241 · cited 1×
“Then, we used the GLST command to carry out the dose-response metaanalysis, which required cases, person-years and dose converted from BMI, as well as BMI level-specific RRs with variance estimated for at least 3 quantitative classifications of each article.([24]) We calculated the nonlinear P-value by testing the nul…”
Research works printed but not linked: 2
- Danhe Zhao Research progress on the correlation between obesity related factors and cancer. Cancer Res Clin 2016; 28: 426– 9.
- Zhang B Deng X Zhu P Research progress on the correlation between obesity and renal cancer. J Mod Urol 2017; 22: 962– 6.
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Global epidemiology of kidney cancer
Cirillo, L., Innocenti, S., & Becherucci, F. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae036 · Cited by 168
Update on Adipose Tissue and Cancer
Brown, K. A., & Scherer, P. E. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad015 · Cited by 154
Huang, J., Leung, D. K.-W., Chan, E. O.-T., Lok, V., Leung, S., Wong, I., Lao, X. Q., Zheng, Z., Chiu, P. K., Ng, C., et al. (2021) · European Urology Focus · doi:10.1016/j.euf.2020.12.020 · Cited by 127
Liu, H. X., Ding, G., Yu, W. J., Liu, T. F., Yan, A. Y., Chen, H. Y., & Zhang, A. H. (2019) · Public Health · doi:10.1016/j.puhe.2019.06.010 · Cited by 122
Self-citation
Metadata
- Authors
- Liu, X., Sun, Q., Hou, H., Zhu, K., Wang, Q., Liu, H., Zhang, Q., Ji, L., & Li, D.
- Affiliations
- Taishan Medical University (CN)
- Traditional Chinese Medical Hospital of Taian, Tai’an, China.
- Corresponding author
- Ji, Long
- Li, Dong
- Venue
- Medicine
- Published
- 2018-11
- Volume
- 97
- Issue
- 44
- Pages
- e12860
- ISSN
- 0025-7974 (ISSN-L)
- 1536-5964
- PMC
- PMC6221676
- OpenAlex
- W2899067744
- Cited by
- 72
- References
- 51
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 11 · 2023: 10 · 2022: 12 · 2021: 8 · 2020: 10 · 2019: 2
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Medicine (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- body mass index, kidney cancer, obesity, overweight, cancer risk, dose-response relationship, sex differences
- MeSH terms
- Female, Humans, Kidney Neoplasms, Male, Obesity, Risk Factors, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The association between BMI and kidney cancer risk: An updated dose-response meta-analysis in accordance with PRISMA guideline. https://app.cochat.ai/papers/10.1097/md.0000000000012860
- The paper
- Liu, X., Sun, Q., Hou, H., Zhu, K., Wang, Q., Liu, H., Zhang, Q., Ji, L., & Li, D. (2018). The association between BMI and kidney cancer risk: An updated dose-response meta-analysis in accordance with PRISMA guideline. Medicine. https://doi.org/10.1097/md.0000000000012860
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.